698 related articles for article (PubMed ID: 25522658)
1. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
Scheffel C; Thiermann H; Worek F
Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
3. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
4. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
6. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
7. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
Horn G; de Koning MC; van Grol M; Thiermann H; Worek F
Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
Worek F; Aurbek N; Thiermann H
J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
[TBL] [Abstract][Full Text] [Related]
11. Acceleration of oxime-induced reactivation of organophosphate-inhibited fetal bovine serum acetylcholinesterase by monoquaternary and bisquaternary ligands.
Luo C; Ashani Y; Doctor BP
Mol Pharmacol; 1998 Apr; 53(4):718-26. PubMed ID: 9547363
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of organophosphate-inhibited human acetylcholinesterase by isonitrosoacetone (MINA): a kinetic analysis.
Worek F; Thiermann H
Chem Biol Interact; 2011 Nov; 194(2-3):91-6. PubMed ID: 21930118
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes.
Worek F; Wille T; Koller M; Thiermann H
Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of interactions of amodiaquine with human cholinesterases and organophosphorus compounds.
Bierwisch A; Wille T; Thiermann H; Worek F
Toxicol Lett; 2016 Mar; 246():49-56. PubMed ID: 26851641
[TBL] [Abstract][Full Text] [Related]
15. Effect of organophosphorus hydrolysing enzymes on obidoxime-induced reactivation of organophosphate-inhibited human acetylcholinesterase.
Herkenhoff S; Szinicz L; Rastogi VK; Cheng TC; DeFrank JJ; Worek F
Arch Toxicol; 2004 Jun; 78(6):338-43. PubMed ID: 14985944
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
[TBL] [Abstract][Full Text] [Related]
17. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study.
Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK
Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352
[TBL] [Abstract][Full Text] [Related]
18. Effect of human plasma on the reactivation of sarin-inhibited human erythrocyte acetylcholinesterase.
Worek F; Eyer P; Kiderlen D; Thiermann H; Szinicz L
Arch Toxicol; 2000 Mar; 74(1):21-6. PubMed ID: 10817663
[TBL] [Abstract][Full Text] [Related]
19. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
[TBL] [Abstract][Full Text] [Related]
20. Exploring the physicochemical properties of oxime-reactivation therapeutics for cyclosarin, sarin, tabun, and VX inactivated acetylcholinesterase.
Esposito EX; Stouch TR; Wymore T; Madura JD
Chem Res Toxicol; 2014 Jan; 27(1):99-110. PubMed ID: 24443939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
